PRCT PROCEPT BioRobotics Corp

Price Chart

Executive Summary

Three PROCEPT executives (CFO, CTO, CLO) sold a combined ~1,000 shares worth ~$28K in open-market transactions on June 8, 2026. Two directors received non-cash stock grants totaling ~18K shares on June 9 with $0 proceeds. The open-market sales are trivial in size — ~0.002% of the $1.6B market cap — and appear routine. The grants add no selling pressure. With $28K of insider selling at a $1.6B company, this cluster has no material trading signal.

Key Financial Metrics

Actionable Insight

Key Facts

• 3 EVP-level insiders sold an aggregate of 1,000 open-market shares for $28K on June 8, 2026 — ~0.002% of market cap
• Director Prescott and Director Puckett each received non-cash grants totaling ~9.2K shares on June 9 — $0 proceeds, no market impact
• Recent 30-day insider activity shows only $28K in total selling, consistent with routine tax- or liquidity-based transactions
• No 10b5-1 plan disclosure is provided in the filing text, but the pattern of small uniform sales (285-358 shares each) is consistent with share withholding or planning

Financial Impact

Total open-market sales of ~$28K represent 0.002% of the $1.6B market cap — immaterial. Non-cash director grants of ~18,336 shares are compensatory and create zero selling pressure.

Risk Factors

• Insider sales at this scale are not predictive; a larger cluster (>$1M in total sales) could emerge near future lockup expirations or earnings blackout windows
• Directors' stock grants add modest dilution that compounds over multiple grant cycles, but the 18K-share grant is less than 0.1% of outstanding shares

Market Snapshot

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

US Market Status